Pinckaers, Hans http://orcid.org/0000-0002-7570-9300
van Ipenburg, Jolique
Melamed, Jonathan http://orcid.org/0000-0003-2844-7990
De Marzo, Angelo http://orcid.org/0000-0003-4847-5307
Platz, Elizabeth A. http://orcid.org/0000-0003-3676-8954
van Ginneken, Bram
van der Laak, Jeroen http://orcid.org/0000-0001-7982-0754
Litjens, Geert http://orcid.org/0000-0003-1554-1291
Funding for this research was provided by:
KWF Kankerbestrijding (KUN 2015-7970)
Article History
Received: 1 September 2021
Accepted: 18 May 2022
First Online: 8 June 2022
Competing interests
: B.v.G. receive funding and royalties from MeVis Medical Solutions AG, (Bremen, Germany), and reports grants and stock/royalties from Thirona, and grants and royalties from Delft Imaging Systems, all outside the submitted work. J.v.d.L. is a member of the advisory boards of Philips, the Netherlands, and ContextVision, Sweden; and received research funding from Philips, the Netherlands; ContextVision, Sweden; and Sectra, Sweden, all outside the submitted work. G.L. reports research grants from the Dutch Cancer Society, the Netherlands Organization for Scientific Research (NWO), and HealthHolland during the conduct of the study, and grants from Philips Digital Pathology Solutions, and consultancy fees from Novartis and Vital Imaging, outside the submitted work. J.M. is supported by Department of Defense Prostate Cancer Research Program, DOD Award No W81XWH-18-2-0016, PCRP Prostate Cancer Biorepository Network A.D.M. is a paid consultant to Cepheid LLC, and Merck & Co., A.D.M has also received research support from Myriad Genetics and Janssen R&D for other studies. All other authors have no competing interests.